HDAC9 and breast carcinoma: Despite detectable HDAC overexpression in some breast cancer subtypes, the ability of HDAC overexpression to predict overall survival (OS) or DFS is less clear; conflicting results were published indicating the potential prognostic value of HDAC6 [102,103] and HDAC2 [101,102,104] expression.